61 studies found for:    Open Studies | "Warfarin"
Show Display Options
Rank Status Study
1 Recruiting To Establish a Novel Prototype of Clinical Pharmacy Services by Warfarin Consultation in a Pharmacist Clinic
Condition: Intentional Warfarin Sodium Overdose
Intervention: Other: patient education
2 Recruiting Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose
Condition: Indications for Warfarin Therapy
Intervention: Drug: Warfarin Sodium
3 Recruiting Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Conditions: Anti-coagulation Therapy;   DVT;   Pulmonary Embolism;   Joint Surgery Multiple;   Atrial Fibrillation;   Prosthetic Replacement of Mitral Valve
Intervention: Device: Warfarin GenoSTAT Test
4 Recruiting Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: edoxaban;   Drug: Enoxaparin;   Drug: Warfarin
5 Recruiting Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"
Conditions: Atrial Fibrillation;   Coronary Artery Disease
Interventions: Drug: Ticagrelor+Warfarin;   Drug: Clopidogrel+Aspirin+Warfarin
6 Unknown  Predictors of Anticoagulation Control on Warfarin Therapy
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Heart Valve Replacement
Intervention:
7 Unknown  Randomized Trial of Interventions to Improve Warfarin Adherence
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Dilated Cardiomyopathies
Interventions: Behavioral: Financial Incentive and Med-eMonitor;   Device: 2Med-eMonitor
8 Recruiting Validation of International Warfarin Pharmacogenetics Consortium (IWPC) Algorithm in Elderly Patients With Comorbidity
Conditions: Atrial Fibrillation;   Thrombus Due to Heart Valve Prosthesis
Intervention: Drug: Warfarin
9 Unknown  Fiix-prothrombin Time for Monitoring Warfarin
Conditions: Thromboembolism;   Arterial;   Venous
Intervention: Device: Fiix prothrombin time
10 Recruiting Pharmacogenetics of Warfarin in Puerto Ricans.
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Antiphospholipid Syndrome;   Coagulopathy
Intervention:
11 Not yet recruiting Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease
Conditions: Atrial Fibrillation;   Chronic Kidney Disease
Interventions: Drug: warfarin;   Drug: aspirin
12 Recruiting Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Pulmonary Embolism;   Heart Valve Disease
Interventions: Other: Genotype-guided warfarin dosing;   Other: Non-genotype guided warfarin dosing
13 Recruiting Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT
Condition: Thromboembolism
Interventions: Genetic: Pharmacogenetic Warfarin Initiation;   Other: Clinical Warfarin Initiation
14 Not yet recruiting Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque
Condition: Atrial Fibrillation
Interventions: Drug: apixaban;   Drug: warfarin
15 Recruiting The Study of Warfarin Maintenance Dose in Chinese Patients
Conditions: Atrial Fibrillation;   Heart Valve Disease;   Pulmonary Artery Embolism
Intervention: Drug: Warfarin
16 Recruiting Therapeutic Equivalence Between Branded and Generic Warfarin Tablets in Brazil
Condition: Atrial Fibrillation
Interventions: Drug: Marevan®;   Drug: generic warfarin #1;   Drug: generic warfarin #2
17 Unknown  VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
Conditions: Atrial Fibrillation;   Cardiac Thrombus;   Deep Vein Thrombosis;   Pulmonary Embolism;   Heart Valve Replacement (Mechanical or Biological With AF);   Cardiomyopathy (Ischemic or Dilated);   Peripheral Vascular Disease
Intervention: Drug: Warfarin dose titration
18 Recruiting Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation Postoperatively
Condition: Primary Disease
Interventions: Drug: Dabigatran;   Drug: Warfarin
19 Recruiting Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin Therapy
Condition: Coagulation Delay
Interventions: Dietary Supplement: phytonadione;   Drug: none-control group
20 Unknown  The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR
Condition: Deep Venous Thromboembolism
Intervention: Drug: warfarin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years